CLNN

MKT CAP:$78M

Clene Inc.

Market Cap

$78M

Consumer Defensive·Packaged Foods·🇺🇸 United States·NASDAQ

Consumer Def.·Packaged Foods·🇺🇸·NASDAQ

Stock Price

$5.45-$0.32 (-5.55%)

Jun 5, 2026

52W High $12.5052W Low $3.36

Company Details

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studie...

CEO

—

IPO Date

Dec 31, 2020

Website

clene.com

Key Metrics TTM

Revenue

$134.0K

-61.7% YoY

Net Income

-$34M

EPS (Diluted)

Free Cash Flow

-$18M

Revenue / Share

$0.01

Gross Margin

-182.1%

Operating Margin

-15535.1%

Net Margin

-25009.7%

FCF Margin

-13509.0%

P/S

582.7x

P/E

Earnings Reports

Q1 2026

May 14, 2026

$15.0K-81.5%

FY 2025

Mar 17, 2026

$200.0K-41.5%

Q4 2025

Mar 17, 2026

$77.0K-15.4%

Q3 2025

Nov 13, 2025

$15.0K-82.8%

Q2 2025

Aug 14, 2025

$27.0K-70.3%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee